Abpro Quote - ABP

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.2345

Bid

0.2345

Offer

0.28

Volume

234,976

0.231 Day's Range 0.27

0.23 52 Week Range 8.80

Market Cap

12.081M

Previous Close

0.258

Open

0.26

Last Trade

0.2372

Last Trade Time

Financial Volume

US$ 56,622

VWAP

0.240968

Average Volume (3m)

89,757

Shares Outstanding

51,518,605

Dividend Yield

PE Ratio

105.29

Earnings Per Share (EPS)

0.05

Revenue

Net Profit

2.82M

Abpro Corporation, a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for t... Abpro Corporation, a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers, and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as IE LAB Inc. and changed its name to Abpro Corporation in October 2007. Abpro Corporation was incorporated in 2004 and is headquartered in Woburn, Massachusetts. Show more

Sector

Blank Checks

Industry

Biological Pds,ex Diagnstics

Website

www.abpro.com

Headquarters

Wilmington, Delaware, USA

Founded

2021

Abpro Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker ABP. The last closing price for Abpro was US$0.26. Over the last year, Abpro shares have traded in a share price range of US$ 0.23 to US$ 8.80.

Abpro currently has 51,518,605 shares in issue. The market capitalisation of Abpro is US$13.29 million. Abpro has a price to earnings ratio (PE ratio) of 105.29.

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

WOBURN, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing...

Abpro Statement on the Departure of Former CEO Ian Chan

WOBURN, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing...

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

Business combination closed November 13, 2024Raised $10 million of gross proceeds in connection with the business combinationAgreements are in...

Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0645	-21.5719063545	0.299	0.299	0.2302	189643	0.26313846	CS
4	-0.2185	-48.233995585	0.453	0.490199	0.23	162550	0.29619688	CS
12	-1.0755	-82.0992366412	1.31	1.35	0.23	89757	0.46454732	CS
26	-4.9655	-95.4903846154	5.2	8.8	0.23	469944	1.80863097	CS
52	-4.9655	-95.4903846154	5.2	8.8	0.23	469944	1.80863097	CS
156	-4.9655	-95.4903846154	5.2	8.8	0.23	469944	1.80863097	CS
260	-4.9655	-95.4903846154	5.2	8.8	0.23	469944	1.80863097	CS

ABP - Frequently Asked Questions (FAQ)

What is the current Abpro share price?

The current share price of Abpro is US$ 0.2345

How many Abpro shares are in issue?

Abpro has 51,518,605 shares in issue

What is the market cap of Abpro?

The market capitalisation of Abpro is USD 13.29M

What is the 1 year trading range for Abpro share price?

Abpro has traded in the range of US$ 0.23 to US$ 8.80 during the past year

What is the PE ratio of Abpro?

The price to earnings ratio of Abpro is 105.29

What is the reporting currency for Abpro?

Abpro reports financial results in USD

What is the latest annual profit for Abpro?

The latest annual profit of Abpro is USD 2.82M

What is the registered address of Abpro?

The registered address for Abpro is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Abpro website address?

The website address for Abpro is www.abpro.com

Which industry sector does Abpro operate in?

Abpro operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UPXIUpexi Inc	US$ 9.83 (328.32%)	100.38M
SHFSSHF Holdings Inc	US$ 4.17 (87.00%)	43.5M
MLGOMicroAlgo Inc	US$ 11.84 (74.63%)	78.43M
MKDWMKDWELL Tech Inc	US$ 0.4027 (73.35%)	40.8M
MTENMingteng International Corporation Inc	US$ 6.24 (47.87%)	317.66k
AIEVThunder Power Holdings Inc	US$ 0.049999 (-63.02%)	6.25M
LXEHLixiang Education Holding Company Ltd	US$ 2.88 (-57.89%)	1.57M
AREBAmerican Rebel Holdings Inc	US$ 2.38 (-53.88%)	11.97M
SXTCChina SXT Pharmaceuticals Inc	US$ 1.029 (-52.36%)	1.66M
RTCBaijiayun Group Ltd	US$ 0.1862 (-49.68%)	7.75M
DMNDamon Inc	US$ 0.0041 (20.59%)	621.47M
NVDANVIDIA Corporation	US$ 96.91 (-4.51%)	288.68M
STSSSharps Technology Inc	US$ 0.0319 (-0.31%)	162.99M
RSLSReShape Lifesciences Inc	US$ 0.383 (23.67%)	152.04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 6.7742 (-11.68%)	151.31M